We describe the histological examination of 18 aborted fetuses that had increased nuchal translucency (NT) between 11 q0 and 13 q6 weeks' gestation. The aim of this study was to assess the corresponding NT anatomic features by immunohistochemical (IHC) investigation. A morphological study was performed using lymphatic and blood endothelial specific markers, as well as smooth muscle actin (SMA). We found that all 18 cases were D2-40 positive, CD31 positive, and CD34 negative, suggesting the presence of nuchal lymph vessel ectasia. We found that 12/18 cases were SMA staining positive and 6/18 cases were SMA negative, suggesting that 6/18 cases had nuchal cystic lymphangiectasia, whereas 12/18 had cystic hygromas. The present data seem to confirm the reasonable hypothesis that lymphangiogenesis plays a relevant role in nuchal edema, increased NT, and that increased NT is the result of a lymphatic malformation or a delayed development of the lymphatic system.
Introduction
Fetal nuchal translucency (NT) is a small translucent area in the posterior fetal neck w18x which can be visualized by ultrasound examination between the 11 q0 and 13 q6 weeks of gestation (Fetal Medicine Foundation, London, UK: http://www.fetalmedicine.com/). NT usually disappears after 14 weeks of gestation w15x. Increased NT is defined as )95 th percentile and represents edema behind the fetal neck. It has been established that measuring NT between the 11 q0 and 13 q6 weeks' gestation, together with maternal age and serum biochemistry is a sensitive, accurate and effective method of first-trimester screening for chromosomal abnormalities w14, 19x. The higher the NT, the greater the probability of aneuploidy, cardiac defects, anomalies, and genetic syndromes. Although NT measurement is performed worldwide and a commonly used screening method, its pathophysiology is still unclear w4, 8, 9, 12x. This paper describes a retrospective histological examination of 18 aborted fetuses that had increased NT between the 11 q0 and 13 q6 weeks' gestation. The aim of this study was to relate the NT anatomic features to immunohistochemical findings.
Materials and methods
This was a retrospective cohort study reviewing 1098 autopsy files. Figure 1 shows the subject inclusion-exclusion flow-chart. All fetuses were prenatally examined by ultrasound and diagnosed as normal or increased NT measurement performed between the 11 q0 and 13 q6 weeks' gestation. The fetuses were karyotyped by chorionic villus sampling or amniocentesis. Termination of the pregnancy was performed at the request of the parents for medical or psychosocial reasons, according to the current Italian law (Law 194/1978) . The medical Ethical Committee approved the study. All parents received information and gave written informed consent.
Autopsies of retrieved-scheduled cases were performed according to a previously described protocol w11x. Consecutive parallel sections were obtained cutting along cross-sectional planes. Of all the sections, the one running from the mental spine, at the lower jawbone margin, to the third cervical vertebra was the reference section to fully examine the nuchal region.
Five m thick microtome sections were obtained from paraffin blocks used for routine hematoxylin and eosin staining and for immunohistochemical (IHC) investigations. The following monoclonal antibodies were used: CD31 antibodies (Dako, Glostrup, Denmark, 1A10), CD34 (Dako, Glostrup, Denmark, QBEnd10) w17x, D2-40 (Signet, England, D2-40), smooth muscle actin (SMA) (Ventana, Arizona, USA, 1A4) w15, 16x. D2-40 was diluted 1:120 and incubated for 60 min at room temperature. Antigenic unmasking was carried out using subsequent microwave cycles (each cycle takes from 4 to 32 min at 378C) except for SMA. A Ventana kit was employed for endogenous Biotin block. CD31 is platelet endothelial cell adhesion molecule-1 (PECAM-1) that is highly specific for lymphatic and bloodvascular endothelium w16x. CD34 is expressed by embryonic cells of the hematopoietic system, including endothelial cells that are present in blood-vascular vessels w17x. SMA antibody is useful for identifying smooth muscle cells of the bronchial and bronchiolar wall as well as of vessel wall. It can stain myofibroblasts and muscle cells in the intima and in the media of small and medium caliber lymph vessels w6, 16, 17x. Podoplanin is a transmembrane mucoprotein that is recognized by the D2-40 monoclonal antibody. D2-40 is a selective monoclonal immunohistochemical marker of lymphatic endothelium on formalinfixed and paraffin-embedded tissue specimens w10x.
Results
We identified 18 fetuses that matched our inclusion criteria (Figure 1) . The main characteristics of the fetuses and the IHC results are summarized in Table 1 . Results of the histological examination related to the nuchal region as performed by H&E staining in tissue samples from all 18 enrolled fetuses suggested the presence of lymph vessel lesions at the nuchal level (Figure 2 , panels A1 and A2). IHC studies demonstrated that the endothelial profile along optically empty spaces at the nuchal level were D2-40 positive, CD31 positive, and CD34 negative in all 18 enrolled fetuses (Figure 2 , panels B1 and B2). SMA staining was highly positive in 12/18 cases and practically absent (i.e., negative) in the other 6/18 cases (Figure 2 , panels C1 and C2; Table 1 ).
Discussion
We used IHC methods to examine the nuchal lymphatic system of 18 aborted fetuses with increased NT meas- ured between the 11 q0 and 13 q6 weeks' gestation. The use of CD31, CD34, and D2-40 staining allowed us to conclude that the nuchal cavities are formed by lymphatic ectasia with accumulation of fluid. The demonstration that 12/18 cases were SMA positive suggested the venous characteristic of the lesion of the lymphatic vessel wall due to the presence of a layer of smooth muscle cells within the lymphatic subendothelium w3x. This result is compatible with a loss of lymphatic identity. Negative SMA staining in the subendothelial lining of the remaining 6/18 cases points to the presence of nuchal lymphatic ectasia, allowing to differentiate between nuchal cystic lymphangiectasia, featuring thin-walled lymphatic vessels with practically no smooth muscle cells, from cystic hygromas, consisting of large collectors or lymphatic cisterns with thick, well structured highly SMA positive walls and thus suggesting a lymphatic maldevelopmental lesion (Figure 2 , panels C1 and C2). Our results (Table 1 ) support the reasonable hypothesis that lymphangiogenesis plays a relevant role in nuchal edema, which eventually leads to increased NT, and that increased NT is the result of a lymphatic malformation or of a developmental delay of the lymphatic system w1, 3x. The lymphatic system begins to develop from the jugular lymphatic sacs that derive from the budding of the internal jugular veins. Subsequent steps comprise the reorganization of the jugular lymphatic sacs into lymphatic nodes, which is usually completed within the first 10 weeks of gestation, and the ingrowth of the thoracic duct into the internal vein, thus connecting several lymphatic vessels. The thoracic duct is the main drainage vessel of lymph fluids w2, 3, 8x.
The presence of smooth muscle cells (SMA positive) in positive CD31 and D2-40 and negative CD34 human fetuses indicates a disturbance of the venous-lymphatic differentiation. This condition points to the presence of a lymphatic dysplastic lesion such as cystic hygroma. On the other hand, the absence of smooth muscle cells, pointing to the presence of simple lymphatic ectasia without clear signs of dysplasia, is compatible with a delayed venous-lymphatic differentiation process, linked to diminished lymphatic transport and drainage that eventually leads to nuchal edema formation. Small caliber lymphatics may acquire SMA staining, thus reflecting either a developmental defect or alternatively, elevated hydrostatic pressure due to lymphatic obstruction. The delayed, but finally normal lymphatic maturation, could explain the transitory appearance of increased NT later than the 14 th week of gestation, which then disappears as pregnancy progresses, whereas the persistent increased NT could be linked to cystic hygroma. Thus, cystic hygroma, lymphangioma, and lymphangiectasia may represent a sort of continuum. We strongly believe that identification by ultrasound in living fetuses is not feasible. We agree with Molina et al. w13x who suggested that the clinical diagnosis of cystic hygroma should be made in the second trimester of pregnancy, thus one could distinguish between increased NT that resolves or is significantly reduced and the cystic hygroma that appears as a persistent cavity in the posterior fetal neck.
It has been reported w3x that nuchal edema in trisomy 21 and in Turner syndrome is probably caused by different mechanisms. In that paper, the authors observed the absence of the jugular lymphatic sac and lymphatic hypoplasia in Turner syndrome, whereas in trisomy 21 they observed nuchal skin lymphatic vessel ectasia. Thus, these data could indicate disrupted lymphatic endothelial cell (LEC) differentiation in trisomy 21 and a lack of LEC differentiation in Turner syndrome. Our study did not allow us to correlate between various IHC patterns and karyotype abnormalities (Table 1) .
To date, few, conflicting, and inconclusive reports are available on this topic w3, 5, 7x. Measuring NT is carried out for a long time, and although several attempts were made to explain the origin of increased NT in aneuploidy, structural anomalies, as well as a great deal of genetic syndromes, no definitive conclusion could be reached. Delayed or, in turn, disturbed fetal lymphatic system development, both of which are expressions of a common developmental process, is a promising field of research. Our study seems to provide further positive clues in this direction. We suggest that the number of postmortem examinations performed on abortuses with increased NT should be increased as should be the recruitment of fetuses older than 14 weeks of gestational age in whom increased NT eventually resolved.
